<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cytogenetic studies were performed in 140 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) at diagnosis </plain></SENT>
<SENT sid="1" pm="."><plain>Chromosome 11 anomalies were found in 7 cases (5%); 2 of these patients had <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA), 2 had <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), 1 had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t), and 2 had <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (CMMoL) according to the French-American-British (FAB) Cooperative Group criteria </plain></SENT>
<SENT sid="2" pm="."><plain>The chromosome 11 abnormalities comprised <z:mp ids='MP_0004027'>trisomy</z:mp> 11 (2 patients), <z:mp ids='MP_0004026'>monosomy</z:mp> 11 (1 patient), del(11)(q23) (2 patients), add(11)(p15) (1 patient), and der(11) t(3;11)(p21;q23) (1 patient) </plain></SENT>
<SENT sid="3" pm="."><plain>Abnormalities involving band q23 of chromosome 11 occurred in 3 cases and were the most common alteration </plain></SENT>
<SENT sid="4" pm="."><plain>However, specific chromosomal alterations were not associated with any FAB classification group </plain></SENT>
<SENT sid="5" pm="."><plain>These findings and their implications in the biology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are discussed </plain></SENT>
</text></document>